Johnson & Johnson Stock News

Johnson & Johnson (JNJ) plans to separate its Consumer Health business into a new publicly-traded company. With this move, JNJ aims to better The post Johnson & Johnson to Separate Consumer Health Business into New Company appeared first on Smarter Analyst .

The world''s largest drugmaker is splitting in two, but what does that mean for shareholders?

Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation Market Players for Global Laparoscopy Devices Market Stryker Corporation, Karl Storz GmbH & Co KG, Boston Scientific Corporation, Medtronic PLC, Intuitive Surgical, (Japan), Karl Storz GmbH, Olympus Corporation, Microline Surgical, Medtronic PLC. Johnson & Johnson, Olympus Corporation, Conmed Corporation

A new market study is released on Global "Minimally Invasive Surgical Instruments Market 2021" with data Tables for historical and forecast years represented with Chats & Graphs with easy to understand detailed analysis. When a wide-ranging Minimally Invasive Surgical Instruments

The OTC Anti-Infective Drug Market research report is one point solution for businesses to evolve, grow, and mature. It provides real-time data collection methods that can track niche products growth that aligns with your goals. The insights and statistical models

Johnson Johnson may be divided soon as there are plans to split it to become two separate companies. With the division, one will operate the pharmaceutical business while the other will be for the consumer

And then there were two or soon, there will be. Healthcare giant Johnson & Johnsons announcement last week that it would split its operations into two entities one focusing on pharma/medical devices and one focusing on consumer products represents a strategic nod to the fact that the direct-to-consumer (D2C) market is a []

Listerine, Band-Aid and Johnsons Babycare products will soon have a new home, as parent company Johnson & Johnson intends to split into two public companies. The post Big split-up plan for J&J appeared first on FMCG Business .

Thomasville National Bank reduced its position in shares of Johnson & Johnson (NYSE:JNJ) by 11.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,772 shares of the companys stock after selling 2,983 shares during the period. Thomasville National Banks []

Salvus Wealth Management LLC lifted its stake in shares of Johnson & Johnson (NYSE:JNJ) by 5.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,561 shares of the companys stock after buying an additional 308 shares during the quarter. Salvus Wealth Management LLCs []

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences. Among the biggest news of the week is Johnson & Johnson''s (NYSE: JNJ ) announcement regarding the spin-off of its Consumer Health business. Eton Pharmaceuticals, Inc. (NASDAQ: ETON )''s topiramate oral solution received approval from the Food and Drug Administration for certain types of seizures in patients two years of age and older and as a preventative treatment of migraine in patients 12 years of age and older. Azurity Pharma, the sponsor of the new drug application, had purchased topiramate, along with two other neurology candidates from Eton. Eton is eligible to receive a $5 million milestone payment and also royalties on sales. Oncorus, Inc. (NASDAQ: ONCR ) was among the biggest decliners of the week following the company''s presentation of early-stage data for a cancer immunotherapy candidate at the Society for Immunotherapy of Cancer conference.

Red Spruce Capital LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.9% in the third quarter, HoldingsChannel reports. The firm owned 11,618 shares of the companys stock after buying an additional 100 shares during the quarter. Red Spruce Capital LLCs holdings in Johnson & Johnson were worth $1,876,000 at the end []

Johnson & Johnson (JNJ.N) on Friday said it would split into two companies, hiving off its consumer health division that sells Band-Aids and Baby Powder from its pharmaceuticals and medical devices business. The separate companies will have to divide up various legal liabilities. Here are the biggest: JOHNSONS BABY POWDER

Taibbi: As America Braces For The Rittenhouse-Verdict Unrest, Profits Soar By Matt Taibbi, published via SubStack The Mayhem Watch is on. Closing arguments in the trial of Kenosha Shooter Kyle Rittenhouse are expected Monday, and after weeks of hype, the country is primed to explode again. Wisconsin governor Tony Evers announced 500 National Guard troops will be on hand for potential post-verdict unrest , which seems almost guaranteed, no matter the result. As with all major news stories lately, the Rittenhouse case saw idiosyncrasies wash away as coverage accumulated, with pundits pounding the trial into yet another generalized referendum on American culture war. Prestige media made Rittenhouse a stand-in for the Proud Boys, January 6th, school board protests, anti-mask protests, QAnon, Blue Lives Matter, Trump, Domestic Terrorism, fascism, school shooters, and every other naughty thing, with everyone from then-candidate Joe Biden to The Intercept blithely declaring him a white supremacist.